Amy Welsh - Agile Thrpe Senior Officer
| AGRXDelisted Stock | USD 2.94 0.08 2.65% |
Executive
Amy Welsh is Senior Officer of Agile Thrpe
| Age | 53 |
| Phone | 609 683 1880 |
| Web | https://www.agiletherapeutics.com |
Amy Welsh Latest Insider Activity
Tracking and analyzing the buying and selling activities of Amy Welsh against Agile Thrpe stock is an integral part of due diligence when investing in Agile Thrpe. Amy Welsh insider activity provides valuable insight into whether Agile Thrpe is net buyers or sellers over its current business cycle. Note, Agile Thrpe insiders must abide by specific rules, including filing SEC forms every time they buy or sell Agile Thrpe'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Amy Welsh over a year ago Acquisition by Amy Welsh of 13500 shares of Agile Thrpe subject to Rule 16b-3 |
Agile Thrpe Management Efficiency
The company has return on total asset (ROA) of (0.9671) % which means that it has lost $0.9671 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.6404) %, meaning that it created substantial loss on money invested by shareholders. Agile Thrpe's management efficiency ratios could be used to measure how well Agile Thrpe manages its routine affairs as well as how well it operates its assets and liabilities.Agile Thrpe currently holds 2.21 M in liabilities with Debt to Equity (D/E) ratio of 3.95, implying the company greatly relies on financing operations through barrowing. Agile Thrpe has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Agile Thrpe's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Marilyn Carlson | Evoke Pharma | 76 | |
| Karen FFPM | Cyclo Therapeutics | N/A | |
| Gregory Sgammato | Amneal Pharmaceuticals, Class | N/A | |
| Timothy CPA | Shuttle Pharmaceuticals | 66 | |
| Kenneth Marshall | Aquestive Therapeutics | 65 | |
| Kara Morley | Lifecore Biomedical | N/A | |
| Michael Lisjak | Cyclo Therapeutics | 50 | |
| Stephen DMD | Painreform | N/A | |
| Jeff Christensen | Assertio Therapeutics | N/A | |
| Rita Keynan | Painreform | 55 | |
| Gene Esq | Shuttle Pharmaceuticals | N/A | |
| Matt Augustson | Lifecore Biomedical | N/A | |
| Pranav Mehta | Amneal Pharmaceuticals, Class | ||
| Mark CPA | Evoke Pharma | 47 | |
| Steve Laninga | Lifecore Biomedical | N/A | |
| John Shulman | Petros Pharmaceuticals | 61 | |
| Sherry Korczynski | Aquestive Therapeutics | N/A | |
| John Hamm | Cumberland Pharmaceuticals | 68 | |
| Paul Schwichtenberg | Assertio Therapeutics | 53 | |
| Lori McKenna | Cyclo Therapeutics | N/A | |
| Stephen Wargacki | Aquestive Therapeutics | 46 | |
Management Performance
| Return On Equity | -13.64 | |||
| Return On Asset | -0.97 |
Agile Thrpe Leadership Team
Elected by the shareholders, the Agile Thrpe's board of directors comprises two types of representatives: Agile Thrpe inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agile. The board's role is to monitor Agile Thrpe's management team and ensure that shareholders' interests are well served. Agile Thrpe's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agile Thrpe's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MD MBA, Senior Officer | ||
| Jason Butch, VP Officer | ||
| Joseph DUrso, Controller | ||
| Robert ME, Senior Officer | ||
| Kathryn PharmD, Advisor | ||
| Alfred Altomari, CEO and President and Director | ||
| Matthew Riley, Head Communications | ||
| Amy Welsh, Senior Officer | ||
| Geoffrey Gilmore, Senior Officer | ||
| Scott Coiante, CFO and VP | ||
| MPH MD, Consultant |
Agile Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agile Thrpe a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.64 | |||
| Return On Asset | -0.97 | |||
| Profit Margin | (0.70) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 633.86 K | |||
| Shares Outstanding | 2.96 M | |||
| Shares Owned By Insiders | 1.13 % | |||
| Shares Owned By Institutions | 10.13 % | |||
| Number Of Shares Shorted | 222.1 K | |||
| Price To Earning | (4.74) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Agile Stock
If you are still planning to invest in Agile Thrpe check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Agile Thrpe's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |